Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.56 | N/A |
| PEG Ratio (TTM) | -0.46 | N/A |
| P/S Ratio (TTM) | 0.28 | N/A |
| P/B Ratio (TTM) | 1.11 | N/A |
| P/FCF Ratio (TTM) | 6.86 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.29 | N/A |
| Price to 5YR AVG FCF Ratio | 113.96 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.45% | N/A |
| ROE (TTM) | 7.86% | N/A |
| Net Profit Margin (TTM) | 2.07% | N/A |
| ROIC 5YR AVG | 11.83% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -31.00% | 19.07% | 20.29% |
| Revenue | -1.89% | 10.83% | 8.84% |
| Net Income | -32.95% | 19.19% | 19.61% |
| Cash Flow | 57.49% | 139.56% | 79.93% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.40 | N/A |
| Quick Ratio (TTM) | 0.84 | N/A |
| D/E Ratio (TTM) | 0.46 | N/A |
| Interest Coverage (TTM) | 2.87 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.10 | N/A |
| LTL to 5YR AVG FCF | 43.27 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.82% | N/A |